Inclusion Conjunctivitis

Inclusion Conjunctivitis General Information

Inclusion Conjunctivitis Symptoms

The presence of this medical condition (Inclusion Conjunctivitis) determines the appearance of a couple of symptoms (reactions) that enable a well trained medical professional set a correct diagnosis after a few medical tests. The first sign of this medical condition is the presence of the so called “follicular conjunctivitis”. The diagnosis for this medical disorder is easily set, as the doctor will surely recognize this medical condition if a prior therapy with antibiotics did not produce any benefits (the initial follicular conjunctivitis has not improved). With the use of gram stains, the doctor will be able to determine the type of micro-organism that has caused the disease.

Most newborn babies who are diagnosed with Inclusion Conjunctivitis start presenting symptoms a few days after their birth. Their conjunctivae and eyelids are swollen. In some cases, the patient’s eyes present symptoms such as an abnormal discharge. In most clinical cases, both of the baby’s eyes are affected by this inflammatory disorder. In the case of the adult form of this medical condition, only one eye is generally affected. The most common symptoms and / or signs that have been associated with the presence of this form of conjunctivitis include the presence of a stringy, abnormal mucus discharge. Some patients who have been diagnosed with Inclusion Conjunctivitis present follicles (little bumps) inside the lower eye lid. Red eyes are quite common among the sufferers of this disorder. In some severe cases, the presence of this inflammatory condition leads to corneal damage; this causes neovascularization (growth of new blood vessels) and visual disturbances (cloudy vision).

Inclusion Conjunctivitis Treatment

The average therapy option that is considered in the case of newborn babies who are suffering from the neonatal form of Inclusion Conjunctivitis is based on the administration of the ointment from of Tetracycline; the ointment should be applied on the patient’s conjunctiva. Other therapies that have proven their effectiveness (and that serve the same purpose) include the intake of the oral form of Erythromycin, or the IV (intravenous) administration of the same medicine (the average therapy span for such cases generally is two weeks). The mother of the infected baby should be treated for cervicitis, while the father should receive an immediate therapy for urethritis. This is very important, even if the parents do not present any symptoms of these disorders.

In the case of grown ups who have been diagnosed with the presence of the adult form of Inclusion Conjunctivitis, the average therapy option is the applying of Tetracycline drops or ointment. Adjacent therapies include the intake of Erythromycin and / or Amoxycillin. These therapies generally last for twenty-one days. Another option is the therapy with Doxycycline. In such cases, the treatment should not last for more than seven days. It is very important for all patients who have been diagnosed with this medical condition (Inclusion Conjunctivitis) to undergo regular clinical check ups (if possible, on a weekly basis). In this way, his or her personal health care provider will be able to closely monitor the progress of the therapy and make any potentially necessary adjustments. It is very important for all individuals to know that the use of the oral form of Tetracycline is not recommended in the case of children (who are suffering from the neonatal form of Inclusion Conjunctivitis) who do not yet have their permanent teeth. Furthermore, the use of this medicine should not be prescribed to pregnant females or to nursing mothers, as this can affect the normal growth of the unborn baby or that of the newborn child.

The untreated form of the neonatal Inclusion Conjunctivitis is known to generally persist for a couple of months (a year at most). In time, the disorder will heal. However, the child may present neovascularization and / or scarring. In the case of adult patients who do not treat their medical condition, the disorder will probably continue for months; in time, it will develop into corneal neovascularization. The available therapy options are not able to reverse the damage that has already been done. However, early therapy for this medical condition may prevent the complications. For further details (pieces information) regarding the most effective treatment options, and about the therapy options that would suit your medical condition best, we advise you to seek the help of a well trained professional.